Corporate and M&A

Working collaboratively with clients, our corporate and M&A team tackles the complex legal and regulatory challenges of large, multi-jurisdictional transactions

Our Corporate and M&A practice specialises in complex transactions for clients in regulated industries, particularly in our chosen sectors: Asset Management and Investment Funds, Technology, Media and Telecoms, Financial Institutions, Energy, Natural Resources, Infrastructure and Construction and Healthcare and Life Sciences. See our Corporate M&A experience.

Our sector specialisation means our teams have a profound understanding of market dynamics and industry developments, allowing our lawyers to provide current and focused advice that gives our clients a strategic advantage.
Our extensive network of lawyers based across Europe, Middle East and Asia (see our locations) enables us to provide integrated support across multiple jurisdictions and to work on a wide range of deals, from large-scale, complex transactions involving global businesses through to mid-market private deals and development capital.

Market recognition

“Simmons & Simmons has recognised strength advising corporates and financial institutions on domestic and international deals. It is highly skilled in a number of areas, including public takeovers, joint ventures and private sales.”

Chambers and Partners UK 2025, Corporate M&A

We are impressed with the support received from both a business and legal perspective. The team is excellent, and one of the greatest strengths is their responsiveness."

Chambers and Partners Europe 2024, Corporate M&A

Our expertise

Private M&A

Our large Private M&A team specialises in complex cross-border transactions in regulated sectors, including Asset Management and Investment Funds, TMT, Financial Institutions, Healthcare and Life Sciences and Energy, Natural Resources & Infrastructure. Our M&A lawyers work alongside our other market-leading practices, including regulatory, competition, employment, tax, real estate, banking, intellectual property, digital business and dispute resolution. Read more.

Private Equity

Our international Private Equity practice advises clients on a range of transactions from cross-border mid-cap to large-cap and venture and development capital transactions. Our team also works on M&A deals for a range of alternative investment funds in regulated industries and on real estate private equity deals. Read more.

Venture Capital

Our team of specialists provides sophisticated, pragmatic advice on venture capital investment transactions, acting for both investors and companies, at all stages from seed to exit. Read more.

Corporate Reorganisations

Our corporate practice has extensive experience advising on large-scale and complex reorganisations, including within a regulated environment. We are particularly well-known for assisting asset managers and other regulated financial entities, alongside our market-leading financial services regulatory practice. Read more.

Corporate Governance and Advisory

Our international corporate team supports clients on all aspects of company law and corporate governance, providing commercial and practical guidance on strategic and time sensitive matters, as well as routine day to day matters. Read more.

Public M&A

We have an established Public M&A practice, advising financial advisers, bidders and targets on public takeovers and activist shareholders. Our team has considerable experience gained from working at major corporates, investment banks and regulatory bodies, including the UK’s Takeover Panel. Read more.

Equity Capital Markets

Our ECM practice is built on specialist integrated UK ECM, US securities laws, financial services regulatory and Listing Rule sponsor transaction expertise. Our team routinely acts on equity offerings, reverse takeovers and complex demergers. Read more.

Listed Company Advisory

Our UK Public Company practice brings together multidisciplinary specialists to offer a complete range of integrated legal services specifically tailored for companies listed on the Main Market or quoted on AIM. Read more.

Our experience

PineBridge

Acquisition by MetLife for $1.2 billion.

Genmab

Acquisition of ProfoundBio for $1.8bn.